KSQ‐4279 was shown to significantly elevate the antitumor function of multiple conventional chemotherapeutic drugs in MDR cancer cell lines driven by ABCB1/ABCG2/ABCC1 overexpression in vitro independently on its own cytotoxicity (Tables S1 and S2 and Figure 1). Here, ABCC1 is linked to cancer.